Current Protein Identity:P00004 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1AKK SOLUTION STRUCTURE OF OXIDIZED HORSE HEART CYTOCHROME C, NMR, MINIMIZED AVERAGE STRUCTURE Deposited 1997-05-22 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 7;293 K
Resolution not provided
1CRC CYTOCHROME C AT LOW IONIC STRENGTH Deposited 1995-03-22 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.08 Å
1CRC CYTOCHROME C AT LOW IONIC STRENGTH Deposited 1995-03-22 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 1–104(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.08 Å
1FI7 Solution structure of the imidazole complex of cytochrome C Deposited 2000-08-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded IMD IMIDAZOLE × 1 HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 5.7;313 K;Pressure 1
NMR sample composition 6mM cytochrome c, 1.2M Imidazole | H2O
NMR sample composition 6mM cytochrome c, 1.2M Imidazole | D2O
Resolution not provided
1FI9 SOLUTION STRUCTURE OF THE IMIDAZOLE COMPLEX OF CYTOCHROME C Deposited 2000-08-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded IMD IMIDAZOLE × 1 HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 5.7;313 K;Pressure 1
NMR sample composition 6mM cytochrome c, 1.2M imidazole | H2O
NMR sample composition 6mM cytochrome c, 1.2M imidazole | D2O
Resolution not provided
1GIW SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C, NMR, MINIMIZED AVERAGE STRUCTURE Deposited 1998-06-17 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 7;293 K;Ionic strength (raw mmCIF value) 100 mM PHOSPHATE;Pressure 1013
NMR sample composition H2O
Resolution not provided
1HRC HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF HORSE HEART CYTOCHROME C Deposited 1994-08-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 1.90 Å
1I5T SOLUTION STRUCTURE OF CYANOFERRICYTOCHROME C Deposited 2001-02-28 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded CYN CYANIDE ION × 1 HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 7;303 K
NMR sample composition 5mM cytochrome c,50mM potassium cyanide | 90% H2O/10% D2O
NMR sample composition 5mM cytochrome c, 50mM potassium cyanide | D2O
Resolution not provided
1LC1 Solution Structure Of Reduced Horse Heart Cytochrome c in 30% Acetonitrile Solution, NMR Minimized Average Structure Deposited 2002-04-04 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 7.2;298 K;Ionic strength (raw mmCIF value) 50mM;Pressure 1
NMR sample composition 5mM FERROCYTOCHROME C 1H; 50mM PHOSPHATE BUFFER; 70% H2O, 30% CD3CN | 70% H2O, 30% CD3CN
Resolution not provided
1LC2 Solution Structure Of Reduced Horse Heart Cytochrome c in 30% Acetonitrile Solution, NMR 30 Structures Deposited 2002-04-04 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 7.2;298 K;Ionic strength (raw mmCIF value) 50mM;Pressure 1
NMR sample composition 5mM FERROCYTOCHROME C 1H; 50mM PHOSPHATE BUFFER; 70% H2O, 30% CD3CN | 70% H2O, 30% CD3CN
Resolution not provided
1M60 Solution Structure of Zinc-substituted cytochrome c Deposited 2002-07-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HES ZINC SUBSTITUTED HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 6.5;293 K;Pressure 1
NMR sample composition 5mM Zn-cytc | 90% H2O, 10% D2O; 90% D2O, 10% D2O
Resolution not provided
1OCD CYTOCHROME C (OXIDIZED) FROM EQUUS CABALLUS, NMR, MINIMIZED AVERAGE STRUCTURE Deposited 1996-07-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 5.7;293 K
NMR sample composition [U-15N] 7-10 mM cytochrome c, 50 mM potassium phosphate | 90% H2O/10% D2O
NMR sample composition [U-13C; U-15N] 15 mM cytochrome c, 50 mM potassium phosphate | 90% H2O/10% D2O
Resolution not provided
1U75 Electron Transfer Complex between Horse Heart Cytochrome c and Zinc-Porphyrin Substituted Cytochrome c Peroxidase Deposited 2004-08-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain B 1–104(104 aa)
Not recorded PO4 PHOSPHATE ION × 2 ZNH PROTOPORPHYRIN IX CONTAINING ZN × 2 HEC HEME C × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;MPD, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K
Resolution 2.55 Å R-free 0.306
1WEJ IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION Deposited 1998-03-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain F 1–104(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 1 HEM PROTOPORPHYRIN IX CONTAINING FE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.4;50MM ZINC ACETATE BUFFER, PH 6.4, 25% (W/V) PEG 4000.
Resolution 1.80 Å R-free 0.256
1WEJ IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION Deposited 1998-03-26 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain F 1–104(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 1 HEM PROTOPORPHYRIN IX CONTAINING FE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.4;50MM ZINC ACETATE BUFFER, PH 6.4, 25% (W/V) PEG 4000.
Resolution 1.80 Å R-free 0.256
2FRC CYTOCHROME C (REDUCED) FROM EQUUS CABALLUS, NMR, MINIMIZED AVERAGE STRUCTURE Deposited 1996-07-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 5.7;293 K
Resolution not provided
2GIW SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C, NMR, 40 STRUCTURES Deposited 1998-06-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–104(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 7;293 K;Ionic strength (raw mmCIF value) 100 mM PHOSPHATE;Pressure 1013
NMR sample composition H2O
Resolution not provided
2N3B Structure of oxidized horse heart cytochrome c encapsulated in reverse micelles Deposited 2015-05-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–105(104 aa)
Not recorded HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 7.4;298 K;Pressure ambient
NMR sample composition 0.15 mM [U-100% 13C; U-100% 15N] protein, 1.5 M H2O, 25 mM sodium phosphate, 105 mM 1-decanoyl-rac-glycerol, 45 mM lauryldimethylamine-N-oxide, 8 mM hexanol, 8.67 M [U-99% 2H] pentane, Deuterated pentane | Deuterated pentane
NMR sample composition 0.15 mM [U-100% 15N] protein, 1.5 M H2O, 25 mM sodium phosphate, 105 mM 1-decanoyl-rac-glycerol, 45 mM lauryldimethylamine-N-oxide, 8 mM hexanol, 8.67 M [U-99% 2H] pentane, Deuterated pentane | Deuterated pentane
Resolution not provided
2PCB CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ELECTRON TRANSFER PARTNERS, CYTOCHROME C PEROXIDASE AND CYTOCHROME C Deposited 1993-04-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–104(104 aa)
Not recorded HEM PROTOPORPHYRIN IX CONTAINING FE × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
3JBT Atomic structure of the Apaf-1 apoptosome Deposited 2015-10-15 Assembly 1 Protein heterocomplex Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain B 1–105(105 aa)
Chain D 1–105(105 aa)
Chain F 1–105(105 aa)
Chain H 1–105(105 aa)
Chain J 1–105(105 aa)
Chain L 1–105(105 aa)
Chain N 1–105(105 aa)
Not recorded DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 7 MG MAGNESIUM ION × 7 HEM PROTOPORPHYRIN IX CONTAINING FE × 7 ELECTRON MICROSCOPY
cryo-EM buffer 20 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT;pH 7.5;20 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT
cryo-EM vitrification conditions Blot for 2.5 seconds before plunging;Cryogen ETHANE
Resolution 3.80 Å
3NBS Crystal structure of dimeric cytochrome c from horse heart Deposited 2010-06-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–105(104 aa)
Chain B 2–105(104 aa)
Not recorded HEC HEME C × 2 PG4 TETRAETHYLENE GLYCOL × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 2.20 Å R-free 0.273
3NBS Crystal structure of dimeric cytochrome c from horse heart Deposited 2010-06-04 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–105(104 aa)
Chain D 2–105(104 aa)
Not recorded HEC HEME C × 2 PG4 TETRAETHYLENE GLYCOL × 1 PEG DI(HYDROXYETHYL)ETHER × 1 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 2.20 Å R-free 0.273
3NBT Crystal structure of trimeric cytochrome c from horse heart Deposited 2010-06-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 2–105(104 aa)
Chain E 2–105(104 aa)
Chain F 2–105(104 aa)
Not recorded HEC HEME C × 3 PG4 TETRAETHYLENE GLYCOL × 3 PEG DI(HYDROXYETHYL)ETHER × 2 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 2.10 Å R-free 0.254
3NBT Crystal structure of trimeric cytochrome c from horse heart Deposited 2010-06-04 Assembly 2 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain B 2–105(104 aa)
Chain C 2–105(104 aa)
Chain D 2–105(104 aa)
Not recorded HEC HEME C × 3 PG4 TETRAETHYLENE GLYCOL × 3 PEG DI(HYDROXYETHYL)ETHER × 2 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 2.10 Å R-free 0.254
3O1Y Electron transfer complexes: Experimental mapping of the redox-dependent cytochrome c electrostatic surface Deposited 2010-07-22 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 NO3 NITRATE ION × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.4;300 K;High concentration of NaNO3 and 10% Ditionite in the wells, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 1.75 Å R-free 0.248
3O1Y Electron transfer complexes: Experimental mapping of the redox-dependent cytochrome c electrostatic surface Deposited 2010-07-22 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 NO3 NITRATE ION × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.4;300 K;High concentration of NaNO3 and 10% Ditionite in the wells, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 1.75 Å R-free 0.248
3O1Y Electron transfer complexes: Experimental mapping of the redox-dependent cytochrome c electrostatic surface Deposited 2010-07-22 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 NO3 NITRATE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.4;300 K;High concentration of NaNO3 and 10% Ditionite in the wells, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 1.75 Å R-free 0.248
3O20 Electron transfer complexes:experimental mapping of the Redox-dependent Cytochrome C electrostatic surface Deposited 2010-07-22 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 NO3 NITRATE ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.4;300 K;Excess of NaNO3 and 10% of Ditionite, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 1.90 Å R-free 0.276
3O20 Electron transfer complexes:experimental mapping of the Redox-dependent Cytochrome C electrostatic surface Deposited 2010-07-22 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 NO3 NITRATE ION × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.4;300 K;Excess of NaNO3 and 10% of Ditionite, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 1.90 Å R-free 0.276
3O20 Electron transfer complexes:experimental mapping of the Redox-dependent Cytochrome C electrostatic surface Deposited 2010-07-22 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 NO3 NITRATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.4;300 K;Excess of NaNO3 and 10% of Ditionite, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 1.90 Å R-free 0.276
3WC8 Dimeric horse cytochrome c obtained by refolding with desalting method Deposited 2013-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–105(104 aa)
Not recorded HEC HEME C × 2 PO4 PHOSPHATE ION × 2 PG4 TETRAETHYLENE GLYCOL × 2 PEG DI(HYDROXYETHYL)ETHER × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;100mM Tris-HCl buffer, 200mM (NH4)2HPO4, 40%(v/v) PEG200, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 1.80 Å R-free 0.208
3WUI Dimeric horse cytochrome c formed by refolding from molten globule state Deposited 2014-04-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–105(104 aa)
Not recorded HEC HEME C × 2 PG4 TETRAETHYLENE GLYCOL × 2 PO4 PHOSPHATE ION × 2 PEG DI(HYDROXYETHYL)ETHER × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;100mM Tris-HCl buffer, 200mM (NH4)2HPO4, 40%(v/v) PEG 200, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 1.80 Å R-free 0.227
4NFG K13R mutant of horse cytochrome c and yeast cytochrome c peroxidase complex Deposited 2013-10-31 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 2–105(104 aa)
Mutation:K13R HEM PROTOPORPHYRIN IX CONTAINING FE × 1 UNX UNKNOWN LIGAND × 1 HEC HEME C × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;15% PEG 3350, 150 mM NaCl, 0.5 mM 1:1 ratio of horse cytochrome c and yeast cytochrome c peroxidase, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 298K
Resolution 2.11 Å R-free 0.236
4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c Deposited 2014-11-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–105(104 aa)
Not recorded HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 2.19 Å R-free 0.282
4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c Deposited 2014-11-12 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2–105(104 aa)
Not recorded HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 3 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 2.19 Å R-free 0.282
4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c Deposited 2014-11-12 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 2–105(104 aa)
Not recorded HEC HEME C × 1 NO3 NITRATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 2.19 Å R-free 0.282
4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c Deposited 2014-11-12 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 2–105(104 aa)
Not recorded HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 2.19 Å R-free 0.282
4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c Deposited 2014-11-12 Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain E 2–105(104 aa)
Not recorded HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 2.19 Å R-free 0.282
4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c Deposited 2014-11-12 Assembly 6 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain F 2–105(104 aa)
Not recorded HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 2.19 Å R-free 0.282
4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c Deposited 2014-11-12 Assembly 7 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 2–105(104 aa)
Chain B 2–105(104 aa)
Chain C 2–105(104 aa)
Chain D 2–105(104 aa)
Chain E 2–105(104 aa)
Chain F 2–105(104 aa)
Not recorded HEC HEME C × 6 CPT Cisplatin × 5 NO3 NITRATE ION × 16 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
Resolution 2.19 Å R-free 0.282
5IY5 Electron transfer complex of cytochrome c and cytochrome c oxidase at 2.0 angstrom resolution Deposited 2016-03-24 Assembly 1 Protein heterocomplex Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain 1 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 1 MG MAGNESIUM ION × 1 NA SODIUM ION × 2 HEA HEME-A × 2 PER PEROXIDE ION × 1 PGV (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE × 4 TGL TRISTEAROYLGLYCEROL × 3 CUA DINUCLEAR COPPER ION × 1 EDO 1,2-ETHANEDIOL × 6 CHD CHOLIC ACID × 4 PEK (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE × 1 CDL CARDIOLIPIN × 2 UNL UNKNOWN LIGAND × 5 PSC (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE × 1 ZN ZINC ION × 1 DMU DECYL-BETA-D-MALTOPYRANOSIDE × 1 HEC HEME C × 1 X-RAY DIFFRACTION
X-ray crystallization conditions BATCH MODE;pH 8;277 K;15mM sodium phosphate, pH 8.0, 0.7% fluorinated octylmaltoside, 0.2% decylmaltoside, 3% ethylene glycol, 5% PEG 4000
Resolution 2.00 Å R-free 0.207
5IY5 Electron transfer complex of cytochrome c and cytochrome c oxidase at 2.0 angstrom resolution Deposited 2016-03-24 Assembly 2 Protein heterocomplex Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain 2 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 1 MG MAGNESIUM ION × 1 NA SODIUM ION × 2 HEA HEME-A × 2 PER PEROXIDE ION × 1 PGV (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE × 3 TGL TRISTEAROYLGLYCEROL × 2 CUA DINUCLEAR COPPER ION × 1 EDO 1,2-ETHANEDIOL × 3 CHD CHOLIC ACID × 4 PEK (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE × 1 CDL CARDIOLIPIN × 2 UNL UNKNOWN LIGAND × 10 PSC (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE × 1 ZN ZINC ION × 1 DMU DECYL-BETA-D-MALTOPYRANOSIDE × 1 HEC HEME C × 1 X-RAY DIFFRACTION
X-ray crystallization conditions BATCH MODE;pH 8;277 K;15mM sodium phosphate, pH 8.0, 0.7% fluorinated octylmaltoside, 0.2% decylmaltoside, 3% ethylene glycol, 5% PEG 4000
Resolution 2.00 Å R-free 0.207
5WVE Apaf-1-Caspase-9 holoenzyme Deposited 2016-12-24 Assembly 1 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric(25) Consistent with protein count
Chain B 1–105(105 aa)
Chain D 1–105(105 aa)
Chain F 1–105(105 aa)
Chain H 1–105(105 aa)
Chain J 1–105(105 aa)
Chain L 1–105(105 aa)
Chain N 1–105(105 aa)
Not recorded DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 7 MG MAGNESIUM ION × 7 HEM PROTOPORPHYRIN IX CONTAINING FE × 7 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.40 Å
5ZKV Solution structure of molten globule state of L94G mutant of horse cytochrome-c Deposited 2018-03-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–105(104 aa)
Mutation:L94G HEC HEME C × 1 SOLUTION NMR
NMR measurement conditions pH 6;298 K;Ionic strength (raw mmCIF value) 0.03 M cacodylate buffer containing 0.1 M NaCl;Pressure 1
NMR sample composition 2 mM [U-99% 13C; U-99% 15N] Molten globule of L94G mutant of horse cytochrome-c, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
6K9I High-resolution three-dimensional structure of horse heart cytochrome C at room temperature Deposited 2019-06-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.4;293 K;1.0-1.5M sodium chloride, 2.7-3.2M ammonium sulfate, 0.1M sodium phosphate
Resolution 1.80 Å R-free 0.199
6K9J 0.98 A three-dimensional structure of horse heart cytochrome C at 110K Deposited 2019-06-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–105(104 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) HEC HEME C × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;1.0-1.5M sodium chloride, 2.7-3.2M ammonium sulfate, 0.1M sodium phosphate
Resolution 0.98 Å R-free 0.153
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain AaA 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain BaB 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain CaC 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain DaD 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain EaE 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 6 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain FaF 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 7 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain GaG 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
6SUV Horse cytochrome c complexed by octa-anionic calixarene Deposited 2019-09-16 Assembly 8 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain HaH 2–105(104 aa)
Not recorded ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
Resolution 2.50 Å R-free 0.237
8ZXR Crystal structure of Ssr1698 in complex with heme c Deposited 2024-06-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 12–22(11 aa)
Not recorded NI NICKEL (II) ION × 1 CL CHLORIDE ION × 2 HEC HEME C × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;Sodium acetate, Sodium formate, Glycerol
Resolution 1.60 Å R-free 0.218
8ZXR Crystal structure of Ssr1698 in complex with heme c Deposited 2024-06-14 Assembly 2 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain B 12–22(11 aa)
Not recorded NI NICKEL (II) ION × 6 CL CHLORIDE ION × 12 HEC HEME C × 6 GOL GLYCEROL × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;Sodium acetate, Sodium formate, Glycerol
Resolution 1.60 Å R-free 0.218
8ZXR Crystal structure of Ssr1698 in complex with heme c Deposited 2024-06-14 Assembly 3 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain B 12–22(11 aa)
Not recorded NI NICKEL (II) ION × 3 CL CHLORIDE ION × 6 HEC HEME C × 3 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;Sodium acetate, Sodium formate, Glycerol
Resolution 1.60 Å R-free 0.218
8ZXR Crystal structure of Ssr1698 in complex with heme c Deposited 2024-06-14 Assembly 4 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 12–22(11 aa)
Not recorded NI NICKEL (II) ION × 2 CL CHLORIDE ION × 4 HEC HEME C × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;Sodium acetate, Sodium formate, Glycerol
Resolution 1.60 Å R-free 0.218